News

Enhancing Regulatory Submissions with Pinnacle 21 for Faster Results

Enhancing Regulatory Submissions with Pinnacle 21 for Faster Results

Transforming Clinical Data Management with Pinnacle 21 Enterprise Plus

Certara, Inc. (Nasdaq: CERT), a leader in the field of biosimulation, has recently introduced a groundbreaking solution known as Pinnacle 21 Enterprise Plus. This innovative platform is designed to greatly enhance the process of preparing and managing necessary data specifications for clinical studies. With a strong emphasis on efficiency, Pinnacle 21 Enterprise Plus is set to revolutionize how clinical and statistical programmers approach dataset creation for regulatory submissions.

Streamlining Data Specification Management

For years, the industry has relied heavily on traditional methods such as spreadsheets for managing data specifications. Unfortunately, these practices are often fraught with challenges, including a high potential for errors, difficulties with version control, and limited collaboration capabilities. Certara's Pinnacle 21 Enterprise Plus directly resolves these issues by providing a unified workspace where teams can collaborate seamlessly, ensuring faster progress from raw data to ready-for-submission datasets.

Key Features of Pinnacle 21 Enterprise Plus

The newly launched Pinnacle 21 Enterprise Plus boasts an intuitive no-code interface aimed at significantly reducing the time needed for drafting mapping specifications. Internal assessments have shown that users can expect up to a 50% decrease in this task, leading to more efficient workflows and timely submissions.

Collaboration Made Easy

One of the standout features of Pinnacle 21 Enterprise Plus is its compatibility with both industry standards like CDISC as well as proprietary requirements tailored to specific organizations. This flexibility ensures that users can easily adapt the platform to meet varying regulatory guidelines, fulfilling both public and private sector demands.

Accelerating the Submission Process

In the context of biopharmaceutical development, time is often of the essence. Slow submission cycles can create significant delays that ultimately hinder patient access to new therapies. Pinnacle 21 Enterprise Plus aims to expedite this process by facilitating earlier and more efficient creation of SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) mapping specifications. By streamlining these essential tasks, companies can mitigate end-of-study delays and enhance their agile response to regulatory requirements.

Building Towards a Future-Proof Platform

William F Feehery, CEO of Certara, articulated the company’s commitment to advancing the field of data sciences through these innovative updates. “By expanding Pinnacle 21, we are investing in the future of data sciences,” he stated, highlighting the importance of these tools in accelerating the regulatory submission process for new treatments.

Endorsements from Global Leaders

Pinnacle 21 Enterprise Plus is already being utilized by over 130 organizations around the globe. Notably, it has gained the trust of leading biopharmaceutical firms and regulatory authorities, including the US FDA and Japan's PMDA. This widespread adoption solidifies Certara’s reputation as an industry pioneer in clinical data standardization and validation.

Certara’s Commitment to Innovation

In a statement reflecting on the evolution of the Pinnacle 21 product suite, Martin Snyder, President of Certara Data Sciences, emphasized the company's goal of creating a comprehensive platform. “We are building a future-proof platform that delivers end-to-end data standardization and validation,” he remarked. The continued enhancements demonstrate Certara's dedication to staying ahead of the curve in this dynamic field.

About Certara

Certara is dedicated to speeding up the development of new medicines through advanced biosimulation software and related services. With a diverse client base encompassing more than 2,400 biopharmaceutical companies, regulatory bodies, and academic institutions across 70 countries, Certara stands at the forefront of innovation in drug discovery and development processes. To learn more about how Pinnacle 21 Enterprise Plus and other solutions can advance your regulatory submissions, visit Certara’s official website.

Frequently Asked Questions

What is Pinnacle 21 Enterprise Plus?

Pinnacle 21 Enterprise Plus is a software solution designed to enhance the management of clinical data specifications, facilitating faster and more accurate regulatory submissions.

How does it improve data specification management?

The platform offers a collaborative workspace and a no-code interface that significantly reduces the time needed to draft mapping specifications, improving efficiency and accuracy.

What benefits does Pinnacle 21 provide?

It ensures compliance with industry standards, facilitates integrations with programming tools, and enables faster submission cycles for regulatory approval.

Who can use Pinnacle 21 Enterprise Plus?

This platform is tailored for clinical and statistical programmers, making it essential for teams involved in data validation and submission processes.

What makes Certara a leader in the industry?

Certara's commitment to innovation, combined with its vast global client base and trusted solutions, positions the company as a leader in clinical data management and biosimulation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SteriLance Aims for Smoother Pricks with NanoSense Move

Updated Category News Views 92

Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...

Continue Reading
Ridgeline’s Dome Roof Award Signals Durable Craft Demand

Updated Category News Views 11

A faceted dome in the Alabama woods is about as far from a cookie-cutter reroof as it gets. Ridgeline Roofing & Restoration’s 2026 Excellence Award from Brava Roof Tile matters because the job in Pell City demanded the sort of painstaking field execution that separates a capable contractor from a crew merely moving shingles fast. Geometry Is Where Easy Claims Go to Die...

Continue Reading
Halff Elevates People and Delivery Leadership Team

Updated Category News Views 43

Infrastructure outfits rarely make much noise when they reshuffle leadership, but Halff’s Nov. 18 announcement deserves a closer look than the usual executive-title confetti. The employee-owned consulting firm has put Greg Carpenter in the chief people officer seat and named Leigh Hollis chief delivery officer. One role is aimed squarely at the human machinery; the...

Continue Reading
Fall Pest Risks Linger as Mild Weather Extends Threat

Updated Category News Views 16

A cold snap is not a magic off switch for mosquitoes, ticks, or rodents, and that is the sober point behind the National Pest Management Association's fall and winter 2026 Public Health Pest Index. The group is flagging conditions, not predicting that every household in a named city will face an infestation or illness. Still, mild temperatures, rain, flooding, and plenty...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 234

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Polsen Flex Deal Puts Pre-Tax Funds Behind Wearables

Updated Category News Views 114

A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a...

Continue Reading
Microsoft-Intel Azure Pact Puts Systems Work First

Updated Category News Views 18

Azure’s next bottleneck may be the plumbing between chips, not the chips alone. Microsoft and Intel announced on Nov. 18, 2026, a long-term expansion of their already ancient partnership aimed at shaping select pieces of Azure infrastructure for cloud and AI demand. That sounds dry, because infrastructure announcements usually do. But this one deserves a closer look: it...

Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft

Updated Category News Views 134

Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...

Continue Reading
Redseer's $5M Bet on Faster MENA Decision Intelligence

Updated Category News Views 65

Speed has become the expensive commodity in Middle Eastern commerce, and Redseer is putting roughly $5 million behind the idea that executives will pay to get it. Its newly launched Benchmarks MENA 2.0 platform combines proprietary market data with strategic advisory across nine MENA markets. That sounds like another corporate dashboard pitch until you consider the target...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 180

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Future of Generative AI Chipset Market Growth

Updated Category News Views 252

Generative AI Chipset Market Size Analysis The Generative AI Chipset Market is experiencing remarkable growth as the demand for high-performance AI hardware accelerates across various industries. Currently valued at approximately USD 37.29 billion in 2023, the market is anticipated to reach an impressive USD 454.50 billion by 2032, representing a staggering compound...

Continue Reading
CrateDB Welcomes Robert Ekstrom as New Chief Executive Officer

Updated Category News Views 297

CrateDB Welcomes Robert Ekstrom as New Chief Executive Officer CrateDB, the groundbreaking real-time database solution designed for analytics, search, and AI applications, has announced the exciting appointment of Robert Ekstrom as the new Chief Executive Officer. His leadership is viewed as a pivotal moment for the company, propelling its growth strategies and...

Continue Reading
Novartis AGM Highlights: Board Changes and Dividend Increase

Updated Category News Views 463

Key Outcomes from Novartis' Annual General Meeting Today, Novartis held its Annual General Meeting (AGM) where shareholders gathered to discuss and approve various resolutions proposed by the Board of Directors. It was an important day for the company, as a strong turnout highlighted investor engagement and confidence. Dividend Increase for 2024 This year marks a...

Continue Reading
Understanding Alliance Witan PLC's Net Asset Valuation Insights

Updated Category News Views 116

Understanding Alliance Witan PLC's Financial Standing Alliance Witan PLC stands out in the investment landscape, offering its shareholders a detailed look at their Net Asset Value (NAV). As of the latest reporting date, the financial metrics reveal significant information pertaining to the company's performance and shareholder value. Net Asset Value Calculation At the...

Continue Reading
Remembering Jimmy Carter: A Legacy of Service and Humanity

Updated Category News Views 375

Remembering Jimmy Carter: A Legacy of Service and Humanity Habitat for Humanity joins millions around the globe in reflecting on the remarkable life of former U.S. President Jimmy Carter. He is widely recognized not only as a political leader but also as a formidable advocate for affordable housing. A Champion for Affordable Housing Throughout his life, President Carter...

Continue Reading